Spots Global Cancer Trial Database for metastatic malignant neoplasm in the liver
Every month we try and update this database with for metastatic malignant neoplasm in the liver cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Pembrolizumab With Liver-Directed or Peptide Receptor Radionuclide Therapy for Neuroendocrine Tumors and Liver Metastases | NCT03457948 | Metastatic Mali... Neuroendocrine ... | Arterial Emboli... Pembrolizumab Peptide Recepto... Yttrium-90 Micr... | 18 Years - | University of California, San Francisco | |
| 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis | NCT00862680 | Metastatic Mali... Metastatic Mali... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color... | 4-Dimensional C... 4D PET Scan | 18 Years - | M.D. Anderson Cancer Center | |
| Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions | NCT02156739 | Hepatocellular ... Liver and Intra... Metastatic Mali... Primary Maligna... | Contrast-enhanc... Gadobutrol Gadoxetate Diso... | 18 Years - | M.D. Anderson Cancer Center | |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery | NCT02738606 | Metastatic Colo... Metastatic Mali... Metastatic Mali... Recurrent Color... Resectable Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Chemotherapy Laboratory Biom... Metastasectomy Quality-of-Life... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer | NCT03203525 | Advanced Malign... Colorectal Carc... Metastatic Mali... Refractory Mali... | Bevacizumab Fluorouracil Leucovorin Oxaliplatin Pegylated Lipos... Temsirolimus Tumor Treating ... | 18 Years - | M.D. Anderson Cancer Center | |
| Testing the Use of Chemotherapy After Surgery for High-Risk Pancreatic Neuroendocrine Tumors | NCT05040360 | Metastatic Mali... Pancreatic Neur... Stage I Pancrea... Stage II Pancre... Stage III Pancr... | Capecitabine Temozolomide | 18 Years - | SWOG Cancer Research Network | |
| 4D PET/CT in Diagnosing Participants With Lung and Colorectal Cancer With Liver and Lung Metastasis | NCT00862680 | Metastatic Mali... Metastatic Mali... Stage IV Colore... Stage IV Lung C... Stage IVA Color... Stage IVA Lung ... Stage IVB Color... Stage IVB Lung ... Stage IVC Color... | 4-Dimensional C... 4D PET Scan | 18 Years - | M.D. Anderson Cancer Center | |
| AU409 for the Treatment of Advanced Primary Liver Cancers or Solid Tumor With Liver Metastatic Disease | NCT05791448 | Advanced Cholan... Advanced Hepato... Advanced Malign... Metastatic Mali... Refractory Mali... Stage III Hepat... Stage IV Hepato... | Biospecimen Col... Computed Tomogr... Magnetic Resona... RNA Transcripti... | 18 Years - | University of Southern California | |
| MRI-Guided Stereotactic Body Radiation Therapy in Treating Patients With Liver Metastases or Liver Cancer | NCT02683200 | Adult Hepatocel... Metastatic Mali... | Image-Guided Ad... Stereotactic Bo... | 18 Years - | Jonsson Comprehensive Cancer Center | |
| Trametinib in Treating Patients With Advanced Cancer With or Without Hepatic Dysfunction | NCT02070549 | Advanced Malign... Metastatic Mali... Metastatic Mali... Unresectable So... | Trametinib | 18 Years - | National Cancer Institute (NCI) | |
| Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer | NCT03203525 | Advanced Malign... Colorectal Carc... Metastatic Mali... Refractory Mali... | Bevacizumab Fluorouracil Leucovorin Oxaliplatin Pegylated Lipos... Temsirolimus Tumor Treating ... | 18 Years - | M.D. Anderson Cancer Center | |
| An Investigational Scan (Intravoxel Incoherent Motion Diffusion Weighted Imaging) for the Evaluation of Colorectal Cancer Liver Metastases Treatment Response | NCT04796818 | Metastatic Colo... Metastatic Mali... Resectable Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Diffusion Weigh... | 18 Years - | M.D. Anderson Cancer Center | |
| Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery | NCT02738606 | Metastatic Colo... Metastatic Mali... Metastatic Mali... Recurrent Color... Resectable Colo... Stage IV Colore... Stage IVA Color... Stage IVB Color... | Chemotherapy Laboratory Biom... Metastasectomy Quality-of-Life... Therapeutic Con... | 18 Years - | M.D. Anderson Cancer Center | |
| Short Stitch Versus Traditional Suture for the Prevention of Incisional Hernia After Open Hepatectomy | NCT04982653 | Liver and Intra... Metastatic Mali... Primary Maligna... | Quality-of-Life... Surgical Proced... Surgical Proced... | 18 Years - | M.D. Anderson Cancer Center | |
| Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions | NCT02156739 | Hepatocellular ... Liver and Intra... Metastatic Mali... Primary Maligna... | Contrast-enhanc... Gadobutrol Gadoxetate Diso... | 18 Years - | M.D. Anderson Cancer Center | |
| Contrast-enhanced MRI in Detecting Benign and Malignant Liver Lesions | NCT02156739 | Hepatocellular ... Liver and Intra... Metastatic Mali... Primary Maligna... | Contrast-enhanc... Gadobutrol Gadoxetate Diso... | 18 Years - | M.D. Anderson Cancer Center | |
| Preoperative Immunotherapy (Pembrolizumab) for Patients With Colorectal Cancer and Resectable Hepatic Metastases | NCT03844750 | Metastatic Mali... Stage IV Colore... Stage IVA Color... Stage IVB Color... Stage IVC Color... | Hepatectomy Pembrolizumab Vactosertib | 18 Years - | University of California, San Francisco | |
| Testing Whether Treating Breast Cancer Metastases With Surgery or High-Dose Radiation Improves Survival | NCT02364557 | Anatomic Stage ... Metastatic Brea... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Mali... Metastatic Mali... Prognostic Stag... Anatomic Stage ... | Stereotactic Bo... Surgery | 18 Years - | NRG Oncology |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
